Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 21, 2023
Reporting Period: The filing announces the issuance of a press release containing sales and operating results for the three-month and twelve-month periods ended December 31, 2022.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
Note: Specific financial metrics are not present in the source text provided.
Material Changes
The filing does not detail specific material changes or comparative figures within the text body. It solely references the release of results for the periods ended December 31, 2022.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or contingencies. It states that the information is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 21, 2023) for actual revenue, earnings, and cash flow figures.
- Verify the specific year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any updated full-year 2023 guidance provided in the press release.
- Confirm the status of the company as an emerging growth company (indicated as not elected in the filing).